171 related articles for article (PubMed ID: 36383430)
1. Engineering a HemoMap Nanovaccine for Inducing Immune Responses against Melanoma.
Dai H; Huang Y; Guo J; Li L; Ke Y; Cen L; Meng F; Chen X; Liu B; Qian X
ACS Appl Mater Interfaces; 2022 Nov; 14(47):52634-52642. PubMed ID: 36383430
[TBL] [Abstract][Full Text] [Related]
2. Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma.
Chu Y; Qian L; Ke Y; Feng X; Chen X; Liu F; Yu L; Zhang L; Tao Y; Xu R; Wei J; Liu B; Liu Q
J Nanobiotechnology; 2022 Apr; 20(1):190. PubMed ID: 35418151
[TBL] [Abstract][Full Text] [Related]
3. A dual-adjuvant neoantigen nanovaccine loaded with imiquimod and magnesium enhances anti-tumor immune responses of melanoma.
Chen X; Cen L; Liu Q; Chu Y; Feng X; Ke Y; Zhang Z; Dai H; Huang S; Liu B; Qian X
Biomater Sci; 2022 Nov; 10(23):6740-6748. PubMed ID: 36285738
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
[TBL] [Abstract][Full Text] [Related]
6. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
[TBL] [Abstract][Full Text] [Related]
7. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
[TBL] [Abstract][Full Text] [Related]
8. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
9. In Situ Tumor Vaccine for Lymph Nodes Delivery and Cancer Therapy Based on Small Size Nanoadjuvant.
Zhang H; Zhang Y; Hu H; Yang W; Xia X; Lei L; Lin R; Li J; Li Y; Gao H
Small; 2023 Aug; 19(33):e2301041. PubMed ID: 37078903
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy.
Shi C; Jian C; Wang L; Gao C; Yang T; Fu Z; Wu T
J Nanobiotechnology; 2023 Sep; 21(1):347. PubMed ID: 37752555
[TBL] [Abstract][Full Text] [Related]
11. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
12. Programming peptide-oligonucleotide nano-assembly for engineering of neoantigen vaccine with potent immunogenicity.
Xiang Z; Lu J; Rao S; Fu C; Yao Y; Yi Y; Ming Y; Sun W; Guo W; Chen X
Theranostics; 2024; 14(6):2290-2303. PubMed ID: 38646651
[No Abstract] [Full Text] [Related]
13. Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer.
Zhou L; Hou B; Wang D; Sun F; Song R; Shao Q; Wang H; Yu H; Li Y
Nano Lett; 2020 Jun; 20(6):4393-4402. PubMed ID: 32459969
[TBL] [Abstract][Full Text] [Related]
14. Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy.
Qian Y; Jin H; Qiao S; Dai Y; Huang C; Lu L; Luo Q; Zhang Z
Biomaterials; 2016 Aug; 98():171-83. PubMed ID: 27192420
[TBL] [Abstract][Full Text] [Related]
15. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
[TBL] [Abstract][Full Text] [Related]
16. Carrier-Free Nanovaccine: An Innovative Strategy for Ultrahigh Melanoma Neoantigen Loading.
Zeng T; Zang W; Xiao H; Jiang Y; Lin S; Wang M; Li S; Li L; Li C; Lu C; Yang H
ACS Nano; 2023 Sep; 17(18):18114-18127. PubMed ID: 37695697
[TBL] [Abstract][Full Text] [Related]
17. Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy.
Li Q; Teng Z; Tao J; Shi W; Yang G; Zhang Y; Su X; Chen L; Xiu W; Yuwen L; Dong H; Mou Y
Small; 2022 Aug; 18(32):e2201108. PubMed ID: 35734820
[TBL] [Abstract][Full Text] [Related]
18. Tumor Lysate-Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination Immunotherapy.
Hu X; Wu T; Qin X; Qi Y; Qiao Q; Yang C; Zhang Z
Adv Healthc Mater; 2019 Jan; 8(1):e1800837. PubMed ID: 30506847
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies.
Li J; Li J; Peng Y; Du Y; Yang Z; Qi X
J Control Release; 2023 Jan; 353():423-433. PubMed ID: 36470333
[TBL] [Abstract][Full Text] [Related]
20. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer.
Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H
Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
